Dr. Marc Lambelin
ActiveFrom the official registers: KBO 9 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Dr. Marc Lambelin has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €388,863 and a net result of €370,263. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 68% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 16-06-2017 Normal situation
- Legal form
- Private limited company
- Registered office
- Itegembaan 150, 2590 Berlaar
- Activity
- Other research and development on natural sciences NACE 72109and 1 other
- Establishment unit
- 2.265.203.089 2590 Berlaar, since 16-06-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 01-09-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €503,621
- ▲ 36.6%
- Turnover
- ≈ €1.0m
- estimated
- Profit
- €370,263
- ▲ 35.3%
- Equity
- €388,863
- ▲ 871%
- Total assets
- €490,068
- ▲ 43.0%
Score breakdownlowers riskLiquidity: current ratio 4.19, cash €317,201Equity €388,863 (79.3% of total assets)Sector: Scientific research and development (NACE 72)Size: total assets €490,068Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 83% on liquidity, 90% on profitability and 99% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
The company filed its last 7 accounts on average 44 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Equity rose in 2025from €40,053 to €388,863 ▲ 871% View
- Positive: Higher net result than 95% of companies in research and developmentsector median €27,193 · 615 companies €370,263 View
- Positive: 8 profitable years in a rowprofit 2025: €370,263 8 years View
- Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 21-04-2026
- Annual accounts 2024filed on 17-06-2025
- Annual accounts 2023filed on 20-06-2024
- Annual accounts 2022filed on 11-07-2023
Acts in the Belgian Official Gazette
- Legal-form changeact of 08-12-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Dr. Marc Lambelin
- What is the company number of Dr. Marc Lambelin?
- The company number of Dr. Marc Lambelin is 0676.878.173. The VAT number is the same number with BE in front: BE 0676.878.173.
- Where is Dr. Marc Lambelin based?
- The registered office is at Itegembaan 150, 2590 Berlaar.Company details
- What does Dr. Marc Lambelin do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of Dr. Marc Lambelin?
- The legal form of Dr. Marc Lambelin is Private limited company (BV).
- When was Dr. Marc Lambelin founded?
- Dr. Marc Lambelin was founded on 16-06-2017.
- Is Dr. Marc Lambelin still active?
- Yes, Dr. Marc Lambelin is an active enterprise in the KBO register.
- What is the turnover of Dr. Marc Lambelin?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €503,621 and 881 comparable companies of the same size. It probably lies between €700,000 and €1.5m. It is a rough estimate.Financials
- Is Dr. Marc Lambelin profitable?
- In financial year 2025, Dr. Marc Lambelin made a profit of €370,263.
- Where can I find the annual accounts of Dr. Marc Lambelin?
- Dr. Marc Lambelin filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of Dr. Marc Lambelin due?
- Dr. Marc Lambelin must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Comparable companies
These companies have the same main activity as Dr. Marc Lambelin: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €519,000 and €881,000, founded between 2014 and 2019.
| Company | Total assets | Gross margin |
|---|---|---|
| Dr. Marc Lambelin Berlaar | €490,068 | €503,621 |
| DGBO Oud-Turnhout | €880,605 | €538,264 |
| TRACE Leuven | €536,152 | €883,219 |
| Stijn Jonckheere Harelbeke | €591,179 | €663,366 |
| Kreavet Beveren-Kruibeke-Zwijndrecht | €518,511 | €465,369 |
| PARALLAXTER Koekelberg | €594,553 | €519,928 |
| SILLAR CLINICAL Sint-Martens-Latem | €811,427 | €637,414 |
Next steps
See how customers, suppliers and banks see your own company and what to improve first.